Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. Income Statement 2016–2021
| Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 1.1M | 975,000 | 0 | 0 | 0 | 0 |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -87.7M | -78.9M | -86.7M | -60.7M | -27.0M | -9.4M |
| EBITDA | -85.1M | -77.0M | -83.7M | -59.0M | -26.7M | -9.3M |
| Net Income | -90.3M | -81.6M | -86.3M | -61.7M | -27.6M | -9.7M |
| Per Share Data | ||||||
| EPS (diluted) | — | $-2.44 | $-3.36 | $-2.10 | $-1.23 | $-0.43 |
| Shares Outstanding (dil.) | — | 33M | 26M | 29M | 22M | 22M |
Kaleido Biosciences Inc. Income Statement — FAQ
Kaleido Biosciences Inc. (KLDO) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's income statement history?
The chart and table above show Kaleido Biosciences Inc.'s income statement by year and by quarter, including the growth rate.